Banka BioLoo Ltd. (BANKA) AI Stock Analysis

• Market Cap: ₹591.57M
• Dividend Yield: N/A
• Average Volume (3M): 13.49K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.36
• Revenue Growth: -4.57%
• EPS Growth: 23.01%
• Country: IN
• Employees: 1,111
• Sector: Services
• Sector Strength: N/A
• Industry: Industrial - Pollution & Treatment Controls
• EPS (TTM): -0.14
• Shares Outstanding: 10,846,582
• 10 Day Avg. Volume: 8,574
• 30 Day Avg. Volume: 13,495
• PEG Ratio: >-0.01
• Price to Book (P/B): 2.48
• Price to Sales (P/S): 1.44
• P/FCF Ratio: -11.24
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: ₹52.00 ▼(-22.13% Downside)
• Action: Upgraded Date: 12/03/25
• Date: Action: Upgraded 12/03/25

Banka BioLoo Ltd. faces significant financial and technical challenges, with declining revenues, negative profitability, and bearish market momentum. The negative P/E ratio and lack of dividend yield further weaken its valuation. These factors collectively result in a low overall stock score.

Positive Factors

Moderate Leverage

A moderate debt-to-equity ratio indicates the company uses leverage without excessive financial risk, supporting the ability to finance project-based capex and working capital needs. Over months, this balance can sustain project execution and steady operations without forcing rapid deleveraging.

Diversified Revenue Streams

Having product sales, turnkey project income, and recurring service/maintenance revenue provides multiple cash sources. Durable service contracts and spare-parts demand can smooth revenue volatility from one-time projects, helping stabilize cash flow and customer relationships over a medium-term horizon.

Niche Market & Institutional End-Markets

Specialization in bio-digester systems for rail, institutional and community sanitation positions the company in large, under-served infrastructure niches. Persistent public and institutional sanitation needs create a structural addressable market and recurring procurement opportunities over coming months.

Negative Factors

Declining Revenue & Profitability

Sustained revenue contraction and negative operating profitability erode the firm's ability to invest in product development, margin improvement, and service quality. Over the medium term this reduces competitiveness, limits economies of scale, and may necessitate cost cuts that impair growth.

Negative Cash Flows

Negative operating and free cash flows indicate the company cannot self-fund capital needs or normal operations, making it reliant on external financing. This weakens resilience to shocks, constrains reinvestment in maintenance or expansion, and raises refinancing risk over several months.

Eroding Shareholders' Equity

A shrinking equity base reduces the balance-sheet cushion against losses and limits borrowing capacity. Over time this can raise solvency concerns, force more expensive funding, and restrict the company's ability to bid on larger institutional projects or sustain longer sales cycles.

Banka BioLoo Ltd. Business Overview & Revenue Model

Company Description

Banka BioLoo Limited provides products and services for sanitation and waste management system in India. It manufactures, supplies, and installs bio-toilets. The company is also involved in the operation and maintenance of bio-toilets for Indian railways; setting-up of fecal sludge treatment plants and packaged sewage treatment plants; and refurbishment of sewage treatment plants for complexes. The company was incorporated in 2012 and is based in Hyderabad, India.

How the Company Makes Money

Banka BioLoo Ltd. generates revenue through the sale of its bio-toilet systems, which are marketed to both government and private sectors. The company earns income from direct sales of its products, including various models of bio-toilets tailored for different applications, such as individual households, schools, and public facilities. Additionally, BANKA may offer installation and maintenance services as part of its business model, creating a recurring revenue stream. Strategic partnerships with government initiatives and NGOs focused on sanitation projects further enhance its revenue potential. The company may also profit from the sale of biogas and organic fertilizer produced through the bio-digestion process, tapping into the growing demand for sustainable agricultural inputs.

Banka BioLoo Ltd. Financial Statement Overview

Summary

Banka BioLoo Ltd. is facing significant financial challenges, with declining revenues, negative profitability, and cash flow difficulties. The moderate debt-to-equity ratio is a positive aspect, but overall financial health is under pressure due to shrinking equity and persistent losses.

Income Statement

Banka BioLoo Ltd. has experienced a decline in revenue and profitability over the years. The gross profit margin has decreased significantly from a strong position, and the company is currently reporting negative EBIT and net income, indicating challenges in profitability and operational efficiency. The revenue growth rate has been negative in the most recent year, highlighting a contraction in sales.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio, indicating a balanced approach to leveraging. However, the stockholders' equity has been decreasing, reflecting potential financial strain. The equity ratio remains stable but does not offset the risks associated with declining equity and increasing liabilities.

Cash Flow

Cash flow analysis reveals a negative free cash flow, indicating the company's inability to generate sufficient cash to cover its capital expenditures. The operating cash flow has also turned negative recently, which is concerning for sustaining operations without external financing. The free cash flow to net income ratio is unfavorable, pointing towards cash flow difficulties.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	524.29M	541.74M	499.96M	423.50M	387.51M	304.58M
Gross Profit	248.99M	9.87M	337.57M	368.11M	320.30M	266.47M
EBITDA	-32.98M	-28.60M	41.85M	66.06M	58.91M	39.31M
Net Income	-91.94M	-89.09M	-6.53M	25.39M	31.08M	22.05M
Balance Sheet
Total Assets	0.00	821.55M	774.23M	652.07M	640.54M	463.71M
Cash, Cash Equivalents and Short-Term Investments	46.49M	40.70M	16.88M	13.41M	8.29M	43.35M
Total Debt	0.00	347.28M	259.13M	167.15M	184.96M	116.99M
Total Liabilities	-315.85M	505.70M	376.61M	251.09M	265.52M	163.43M
Stockholders Equity	315.85M	315.13M	397.20M	400.99M	375.02M	300.28M
Cash Flow
Free Cash Flow	0.00	-69.53M	-72.06M	9.40M	-36.00M	53.55M
Operating Cash Flow	0.00	-24.71M	27.63M	73.53M	-4.40M	58.64M
Investing Cash Flow	0.00	-63.44M	-100.69M	-57.18M	-27.17M	-283.29K
Financing Cash Flow	0.00	87.50M	67.76M	-33.29M	9.55M	-36.86M

Banka BioLoo Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 66.78
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BANKA, the sentiment is Negative. The current price of 66.78 is above the 20-day moving average (MA) of 60.04, above the 50-day MA of 62.61, and below the 200-day MA of 75.26, indicating a bearish trend. The MACD of -1.51 indicates Positive momentum. The RSI at 27.27 is Positive, neither overbought nor oversold. The STOCH value of 9.60 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BANKA.

Banka BioLoo Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SPECIALITY	56 Neutral	₹4.83B	15.98	―	0.87%	6.66%	-21.40%
Sector *	55 Neutral	$13.29B	17.42	10.03%	0.93%	7.13%	-12.93%
MAHEPC	54 Neutral	₹3.11B	13.84	―	―	17.09%	―
BANKA	41 Neutral	₹591.57M	-122.34	―	―	-4.57%	23.01%
IL&FSENGG	40 Underperform	₹3.30B	-237.21	―	―	-6.13%	98.35%